Table Image from Scientific Research

Study schema, with post-randomisation site and cluster assignments, for the trial in which new enrolments began on 7 March 2022, and are scheduled to end on 27 August 2023. The schema also shows unplanned study enrolment interruptions due to Ebola Virus Disease lockdowns between 18 October 2022, and 11 December 2022, and planned enrolment interruptions due to low anticipated enrolment during the annual holiday period between 12 December 2022 and 15 January 2023

DOI